| Tight junction proteins and signaling pathways in cancer and inflammation: a functional crosstalk AA Bhat, S Uppada, IW Achkar, S Hashem, SK Yadav, M Shanmugakonar, ... Frontiers in physiology 9, 1942, 2019 | 411 | 2019 |
| Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway IW Achkar, N Abdulrahman, H Al-Sulaiti, JM Joseph, S Uddin, F Mraiche Journal of translational medicine 16, 1-12, 2018 | 207 | 2018 |
| Role of non receptor tyrosine kinases in hematological malignances and its targeting by natural products KS Siveen, KS Prabhu, IW Achkar, S Kuttikrishnan, S Shyam, AQ Khan, ... Molecular cancer 17, 1-21, 2018 | 148 | 2018 |
| Anticancer potential of sanguinarine for various human malignancies IW Achkar, F Mraiche, RM Mohammad, S Uddin Future medicinal chemistry 9 (9), 933-950, 2017 | 73 | 2017 |
| Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells KS Prabhu, KS Siveen, S Kuttikrishnan, A Iskandarani, M Tsakou, ... PLoS One 12 (7), e0180895, 2017 | 52 | 2017 |
| Sanguinarine induces apoptosis pathway in multiple myeloma cell lines via inhibition of the JaK2/STAT3 signaling S Akhtar, IW Achkar, KS Siveen, S Kuttikrishnan, KS Prabhu, AQ Khan, ... Frontiers in Oncology 9, 285, 2019 | 44 | 2019 |
| Embelin: a benzoquinone possesses therapeutic potential for the treatment of human cancer KS Prabhu, IW Achkar, S Kuttikrishnan, S Akhtar, AQ Khan, KS Siveen, ... Future medicinal chemistry 10 (8), 961-976, 2018 | 31 | 2018 |
| Metabolic Signatures of Tumor Responses to Doxorubicin Elucidated by Metabolic Profiling in Ovo IW Achkar, S Kader, SS Dib, K Junejo, SB Al-Bader, S Hayat, AM Bhagwat, ... Metabolites 10 (7), 268, 2020 | 23 | 2020 |
| Dysregulated expression of SKP2 and its role in hematological malignancies M Kulinski, IW Achkar, M Haris, S Dermime, RM Mohammad, S Uddin Leukemia & Lymphoma 59 (5), 1051-1063, 2018 | 17 | 2018 |
| Defining the landscape of metabolic dysregulations in cancer metastasis S Abdul Kader, S Dib, IW Achkar, G Thareja, K Suhre, A Rafii, A Halama Clinical & Experimental Metastasis 39 (2), 345-362, 2022 | 15 | 2022 |
| Oncogenic role of dysregulated leptin signaling in the pathogenesis of ovarian cancer IW Achkar, AA Bhat, M Zafar, M Abbas, OS Khan, S Kuttikrishnan, ... Translational Medicine Communications 4, 1-9, 2019 | 8 | 2019 |
| Metabolic predictors of equine performance in endurance racing A Halama, JM Oliveira, SA Filho, M Qasim, IW Achkar, S Johnson, ... Metabolites 11 (2), 82, 2021 | 7 | 2021 |
| piTracer-Automatic reconstruction of molecular cascades for the identification of synergistic drug targets D Gomari, IW Achkar, E Benedetti, J Tabling, A Halama, J Krumsiek bioRxiv, 2023.04. 08.535933, 2023 | | 2023 |
| Metabolic dysregulations of cancer cells with metastatic potential SA Kader, S Dib, IW Achkar, G Thareja, K Suhre, A Rafii, A Halama bioRxiv, 2021.06. 02.446725, 2021 | | 2021 |
